アトピー性皮膚炎 (アトピー性皮膚炎) とは

Same author

The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.

Journal of psoriasis and psoriatic arthritis·2024

Same author

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

The British journal of dermatology·2021

Same author

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.

The British journal of dermatology·2021

Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026

Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026

Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026

Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026

Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026

Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026

関連する実験動画

アトピー性皮膚炎 (アトピー性皮膚炎) とは

関連する概念動画

The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.

The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

The US Ebola response and the future of global health leadership.

Daniel Mason: a tale of change.

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

関連する実験動画

アトピー性皮膚炎 (アトピー性皮膚炎) とは

関連する概念動画

関連記事

The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.

The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

The US Ebola response and the future of global health leadership.

Daniel Mason: a tale of change.

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?